[PDF][PDF] Reproducibility and generalizability in radiomics modeling: possible strategies in radiologic and statistical perspectives

JE Park, SY Park, HJ Kim… - Korean journal of …, 2019 - synapse.koreamed.org
Radiomics, which involves the use of high-dimensional quantitative imaging features for
predictive purposes, is a powerful tool for developing and testing medical hypotheses …

Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics

M Sollini, L Antunovic, A Chiti, M Kirienko - European journal of nuclear …, 2019 - Springer
Purpose The aim of this systematic review was to analyse literature on artificial intelligence
(AI) and radiomics, including all medical imaging modalities, for oncological and non …

Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement

JE Park, D Kim, HS Kim, SY Park, JY Kim, SJ Cho… - European …, 2020 - Springer
Objectives To evaluate radiomics studies according to radiomics quality score (RQS) and
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or …

Clinical applications of artificial intelligence and radiomics in neuro-oncology imaging

AAK Abdel Razek, A Alksas, M Shehata… - Insights into …, 2021 - Springer
This article is a comprehensive review of the basic background, technique, and clinical
applications of artificial intelligence (AI) and radiomics in the field of neuro-oncology. A …

Quantitative MRI-based radiomics for noninvasively predicting molecular subtypes and survival in glioma patients

J Yan, B Zhang, S Zhang, J Cheng, X Liu… - NPJ Precision …, 2021 - nature.com
Gliomas can be classified into five molecular groups based on the status of IDH mutation,
1p/19q codeletion, and TERT promoter mutation, whereas they need to be obtained by …

MRI biomarkers in neuro-oncology

M Smits - Nature Reviews Neurology, 2021 - nature.com
The central role of MRI in neuro-oncology is undisputed. The technique is used, both in
clinical practice and in clinical trials, to diagnose and monitor disease activity, support …

Oncolytic viro-immunotherapy: an emerging option in the treatment of gliomas

J Zeng, X Li, M Sander, H Zhang, G Yan… - Frontiers in …, 2021 - frontiersin.org
The prognosis of malignant gliomas remains poor, with median survival fewer than 20
months and a 5-year survival rate merely 5%. Their primary location in the central nervous …

Radiomics in neuro-oncology: Basics, workflow, and applications

P Lohmann, N Galldiks, M Kocher, A Heinzel, CP Filss… - Methods, 2021 - Elsevier
Over the last years, the amount, variety, and complexity of neuroimaging data acquired in
patients with brain tumors for routine clinical purposes and the resulting number of imaging …

A systematic review reporting quality of radiomics research in neuro-oncology: toward clinical utility and quality improvement using high-dimensional imaging features

JE Park, HS Kim, D Kim, SY Park, JY Kim, SJ Cho… - BMC cancer, 2020 - Springer
Background To evaluate radiomics analysis in neuro-oncologic studies according to a
radiomics quality score (RQS) system to find room for improvement in clinical use. Methods …

FET PET radiomics for differentiating pseudoprogression from early tumor progression in glioma patients post-chemoradiation

P Lohmann, MA Elahmadawy, R Gutsche, JM Werner… - Cancers, 2020 - mdpi.com
Simple Summary Following chemoradiation with alkylating agents in glioma patients,
structural magnetic resonance imaging (MRI) may suggest tumor progression which …